MM
Marion McCourt
EVP Commercial

Marion McCourt insider trades: Regeneron Pharmaceuticals (REGN) stock sales

EVP Commercial, Regeneron Pharmaceuticals Last trade Oct 30, 2026 77 Form 4 filings
$3.0M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
50
Open-market trades
since 2020
5
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Marion reports to the SEC

Open-market buys and sales

50 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 30, 2026REGN↓ Sell$984K
Sep 3, 2026REGN↓ Sell$2.0M
Nov 1, 2024REGN↓ Sell$845K
Oct 1, 2024REGN↓ Sell$1.1M
Sep 3, 2024REGN↓ Sell$1.2M
Aug 1, 2024REGN↓ Sell$1.2M
Jul 1, 2024REGN↓ Sell$1.2M
Jun 3, 2024REGN↓ Sell$1.1M
May 1, 2024REGN↓ Sell$222K
Apr 1, 2024REGN↓ Sell$241K
Mar 1, 2024REGN↓ Sell$346K
Feb 5, 2024REGN↓ Sell$935K
Feb 1, 2024REGN↓ Sell$258K
Jan 2, 2024REGN↓ Sell$239K
Dec 11, 2023REGN↓ Sell$226K
Nov 1, 2023REGN↓ Sell$784K
Oct 2, 2023REGN↓ Sell$858K
Sep 1, 2023REGN↓ Sell$209K
Aug 1, 2023REGN↓ Sell$186K
Jul 3, 2023REGN↓ Sell$178K
Jun 1, 2023REGN↓ Sell$184K
Apr 3, 2023REGN↓ Sell$901K
Mar 1, 2023REGN↓ Sell$836K
Feb 7, 2023REGN↓ Sell$769K
Feb 1, 2023REGN↓ Sell$827K
Jan 3, 2023REGN↓ Sell$794K
Dec 12, 2022REGN↓ Sell$193K
Dec 1, 2022REGN↓ Sell$832K
Nov 4, 2022REGN↓ Sell$728K
Nov 1, 2022REGN↓ Sell$825K
Oct 3, 2022REGN↓ Sell$776K
Sep 1, 2022REGN↓ Sell$635K
Aug 1, 2022REGN↓ Sell$640K
Jul 1, 2022REGN↓ Sell$647K
Jun 1, 2022REGN↓ Sell$736K
May 2, 2022REGN↓ Sell$723K
Apr 1, 2022REGN↓ Sell$702K
Mar 1, 2022REGN↓ Sell$615K
Feb 1, 2022REGN↓ Sell$607K
Jan 3, 2022REGN↓ Sell$625K
Dec 13, 2021REGN↓ Sell$225K
Dec 1, 2021REGN↓ Sell$639K
Nov 1, 2021REGN↓ Sell$640K
Oct 1, 2021REGN↓ Sell$577K
Sep 1, 2021REGN↓ Sell$675K
Aug 2, 2021REGN↓ Sell$577K
Jul 1, 2021REGN↓ Sell$557K
Jun 7, 2021REGN↓ Sell$512K
May 7, 2021REGN↓ Sell$496K
Oct 5, 2020REGN↓ Sell$1.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other REGN insiders

Open-market trades in the last 12 months

About Marion McCourt's insider trades

Marion McCourt is EVP Commercial at Regeneron Pharmaceuticals (REGN). Since Oct 5, 2020, Marion has reported no open-market purchases and 50 sales worth $34.0M on SEC Form 4. In the last 12 months: 2 sales ($3.0M).

Their filings also include option exercises (35 filings), grants and awards (23 filings), shares withheld for taxes (9 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.